Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel Pd-catalyzed method for (iso)chroman amides using nitroarenes. High yield, scalable process for reliable pharmaceutical intermediate supply.
Patent CN102256981A details a novel route for Anagrelide avoiding toxic nitriles and tin waste, offering cost reduction in pharmaceutical manufacturing and high-purity intermediates.
Novel Pd-catalyzed carbonylation method for quinazolinones using solid CO surrogate. Enhances safety and yield for API intermediates.
Patent CN113045503B discloses a novel Pd-catalyzed carbonylation for 2-CF3 quinazolinones. High-yield, scalable route for API intermediates like Rutaecarpine.
Patent CN113105402B reveals a metal-free iodine-promoted route for 1,2,4-triazoles, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN109096139B discloses a novel metal-free method for preparing alpha-carbonyl amides using water as an oxygen source, offering significant cost and purity advantages for pharmaceutical intermediate manufacturing.
Novel metal-free synthesis for azaspiro tetraenone compounds. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Novel palladium-catalyzed tandem reaction enables efficient one-step synthesis. Reduces complexity and enhances supply chain reliability for pharmaceutical intermediates.
Novel synthesis of axial chiral cyclopentenyl indole-naphthyl compounds via chiral phosphoric acid. High enantioselectivity and cytotoxic activity for pharmaceutical applications.
Novel palladium-catalyzed synthesis offers high efficiency and substrate compatibility for pharmaceutical intermediate manufacturing supply chains.
Patent CN117417339A details Rhodium-catalyzed synthesis offering high purity and scalable production for global pharmaceutical supply chains.
Patent CN112538059B enables high-purity oxazole-4-carboxylic ester manufacturing with atom economy. Reduces waste and cost for pharmaceutical intermediate supply chains globally.
Patent CN103554023B reveals mild ZnCl2 catalysis for high-yield acridine synthesis, offering cost-effective scalable solutions for pharmaceutical intermediates.
Patent CN112898192B details a novel Pd-catalyzed carbonylation route for N-acyl indoles, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN108976198B details a metal-free iodine-catalyzed route for 3-(4-pyridine) indoles. Offers cost reduction in pharma intermediate manufacturing with high purity.
Patent CN113105402A details a metal-free iodine-catalyzed route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN113045489B details a novel Pd-catalyzed aminocarbonylation route for 3-arylquinolin-2(1H)ones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel CuCl-catalyzed route offers cost reduction and scalable production for high-purity pharmaceutical intermediates without anhydrous conditions.
Novel Pd-catalyzed one-pot method for trifluoromethyl chromone quinoline. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Novel axial chiral bisindole catalysts for asymmetric synthesis. Superior stereoselectivity and mild conditions for pharmaceutical intermediates manufacturing.